# OnCo record predicta-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/predicta-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "predicta-biosciences" ;
  schema:name "Predicta Biosciences"@en ;
  schema:alternateName "Predicta"@en ;
  schema:description "Predicta Biosciences sequences the whole genome of myeloma cells, taken either from bone marrow or from the small number that circulate in blood, to tell doctors how risky a person's myeloma is, a step towards replacing repeated bone marrow biopsies with a blood draw."@en ;
  schema:url <https://onco.cc/companies/predicta-biosciences/>, <https://www.predictabiosciences.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.predictabiosciences.com/>, <https://www.predictabiosciences.com/predicta-biosciences-secures-5-2m-to-transform-the-diagnosis-treatment-and-monitoring-of-blood-cancers/>, <https://www.predictabiosciences.com/predicta-biosciences-secures-23-4m-to-scale-its-novel-diagnostic-and-analytics-platform-for-blood-cancers-and-autoimmune-diseases/>, <https://www.predictabiosciences.com/predicta-biosciences-launches-its-first-molecular-diagnostic-product-to-improve-the-prognosis-of-multiple-myeloma/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/smouldering-myeloma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cgp/> .